Psychiatric
Description:
The ASI Self-Report Form asks questions about the following topics: your background and employment, your health and family relationships, your legal situation, and your drug and alcohol use.
Source:
Center for Health Care Evaluation (CHCE)
Tags:
Description:
Developed by a consensus panel, these guidelines provide treatment recommendations for patients with dual disorders.
Source:
U.S. Department of Health and Human Services, SAMHSA
Tags:
- Screening and diagnosis
- Special populations
- Managing challenging patients
- Addiction
- Assessment
- Behavioral therapy
- Comorbidities
- Complicated patients
- Dependence
- Drug interactions
- Expert panel
- Pharmacology
- Pharmacotherapy
- Pharmacy
- Polysubstance use
- Psychiatric
- Psychosocial
- Referral
- Relapse
- Risk factors
- Screening
- Side effects
- Special populations
- Symptoms
- Tolerance
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
- Need to refer
Description:
This guideline discusses management of psychiatric medications in patients receiving buprenorphine/naloxone, and answers the question "How do I manage medications for co-occurring psychiatric disorders in a patient receiving buprenorphine/naloxone (bup/nx) for the treatment of opioid dependence?"
Source:
PCSSmentor.com (1 vote)
Description:
Although professionals identify distinct personality disorders (anti-social, borderline, schizotypal, et al), some personality disordered individuals may not fit in a particular category and yet may clearly deserve this label.</p>
Although classified as mental disorders they may be classified separately and distinguished from the Axis I Clinical Syndromes for some purposes.
Source:
BehaveNet®
Tags:
Description:
This website, funded by SAMHSA, is designed to help physicians to implement office-based buprenorphine treatment using a national network of trained physician mentors.
Source:
Physician Clinical Support System (PCSS) (2 votes)
Tags:
- General information - buprenorphine
- Getting a waiver/setting up your practice
- Logistics of buprenorphine treatment
- Addiction
- Behavioral therapy
- Billing
- Complicated patients
- Contraindications
- CPT
- Diversion
- Dosing
- Drug interactions
- HCPCSs
- Hepatitis
- HIV/AIDS
- Induction
- Methadone
- Pain
- Pregnant
- Psychiatric
- Psychosocial
- Special populations
- Suboxone
- Just became waivered
- Setting up a practice
Description:
Complete overview of substance-induced psychotic disorders.
Source:
Encyclopedia of Mental Disorders (2 votes)
Tags:
Description:
DSM-IV criteria for substance-induced anxiety disorder.
Source:
BehaveNet® (2 votes)
Tags:
Description:
Defines and lists the diagnostic criteria for substance-induced mood disorder.
Source:
All About Depression TM (2 votes)
Description:
This article discusses the abuse and misuse of psychoactive drugs among adults over the age of 50.
Source:
American Journal of Geriatric Pharmacotherapy (3 votes)
Tags:
Description:
This set of guidelines aids physicians in providing detoxification and substance abuse treatment, specifically examining co-occurring medical and psychiatric conditions.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) (3 votes)
